Trend, S., Strunk, T., Hibbert, J., Kok, C. H., Zhang, G., Doherty, D. A., Richmond, P., Burgner, D., Simmer, K., Davidson, D. J. & Currie, A. J.
PLoS One (2015) 10(2):e0117038 PubMed
Davidson lab supported by funding from: MRC and Walter Murdoch Distinguished Collaborator Program
STUDY DESIGN:Breast milk from mothers of preterm infants (?32 weeks gestation) was collected on days 7 (n = 88) and 21 (n = 77) postpartum. Concentrations of lactoferrin, LL-37, beta-defensins 1 and 2, and alpha-defensin 5 were measured by enzyme-linked immunosorbent assay. The antimicrobial activity of breast milk samples against Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, and Streptococcus agalactiae was compared to the activity of infant formula, alone or supplemented with physiological levels of AMPs. Samples of breast milk fed to infants with and without subsequent LOS were compared for levels of AMPs and inhibition of bacterial growth.
RESULTS:Levels of most AMPs and antibacterial activity in preterm breast milk were higher at day 7 than at day 21. Lactoferrin was the only AMP that limited pathogen growth >50% when added to formula at a concentration equivalent to that present in breast milk. Levels of AMPs were similar in the breast milk fed to infants with and without LOS, however, infants who developed LOS consumed significantly less breast milk and lower doses of milk AMPs than those who were free from LOS.
CONCLUSIONS:The concentrations of lactoferrin and defensins in preterm breast milk have antimicrobial activity against common neonatal pathogens.